Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Mana Yahiro"'
Autor:
Mana Yahiro, Rina Okamoto, Risako Fukui, Makoto Aichi, Takahide Iwasaki, Arithoshi Kida, Satoshi Ookawa, Takahiro Kuragano, Miwa Masumoto, Chisa Takata, Yuki Mihara, Masayshi Nanami
Publikováno v:
International Urology and Nephrology. 54:1079-1084
Previous studies reported that the long-acting erythropoiesis-stimulating agent (ESA) significantly suppresses the expression of hepcidin, which regulates iron availability. In this study, we compared the iron availability for erythropoiesis between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91e981d5f791b9e2f64a81e7079654ca
https://doi.org/10.1007/s11255-021-02965-w
https://doi.org/10.1007/s11255-021-02965-w
Autor:
Miwa Masumoto, Makoto Aichi, Masayshi Nanami, Takahide Iwasaki, Mana Yahiro, Arithoshi Kida, Kouske Mizusaki, Takahiro Kuragano, Satoshi Ookawa
Publikováno v:
ASAIO Journal. 68:297-302
We compared the effects on the nutritional condition and health-related quality of life (HR-QoL) of the treatment of patients with on-line hemodiafiltration (OL-HDF) and conventional hemodialysis (CHD) using a superflux dialyzer. In total, 47 mainten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8be5331c4923e1e53422356cf5920884
https://doi.org/10.1097/mat.0000000000001466
https://doi.org/10.1097/mat.0000000000001466
Autor:
Miwa Masumoto, Yuki Mihara, Kazuro Ikawa, Takashi Ueda, Yasuyuki Mimura, Risako Fukui, Takahiro Kuragano, Yoshio Takesue, Mana Yahiro, Norifumi Morikawa, Rina Okamoto, Makoto Aichi
Publikováno v:
Hemodialysis International. 24:528-533
Background Metronidazole-induced encephalopathy (MIE) is a rare disease caused by an adverse reaction to metronidazole (MNZ). Furthermore, the pharmacokinetics of MNZ during hemodialysis (HD) treatment have not been revealed. Case presentation In a 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed01bbae008976ab55e41a0bbad3634f
https://doi.org/10.1111/hdi.12857
https://doi.org/10.1111/hdi.12857
Autor:
Yasuyuki Nagasawa, Yoshimasa Nanami, Aritoshi Kida, Takeshi Nakanishi, Kuragano Takahiro, Mana Yahiro
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Several factors, such as anemia, hypertension, hyperuricemia, metabolic acidosis, and chronic kidney disease (CKD)-mineral and bone disorder (MBD), are associated with the progression of CKD or adverse events in CKD patients. Howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b1d08f148380ebbaf90483e9f570a58
https://doi.org/10.1093/ndt/gfaa142.p0758
https://doi.org/10.1093/ndt/gfaa142.p0758
Publikováno v:
Nephrology Dialysis Transplantation. 34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c8979bd17466bf765026e3a165e1700
https://doi.org/10.1093/ndt/gfz106.fp538
https://doi.org/10.1093/ndt/gfz106.fp538
Autor:
Arithoshi Kida, Mana Yahiro, Takeshi Nakanishi, Yukiko Hasuike, Takahiro Kuragano, Masayoshi Nanami, Yasuyuki Nagasawa
Publikováno v:
Nephrology Dialysis Transplantation. 34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::743cc839c4f4ef8eb494dcbed22eed02
https://doi.org/10.1093/ndt/gfz103.sp356
https://doi.org/10.1093/ndt/gfz103.sp356
Publikováno v:
Contributions to nephrology. 198
With the advancement of technology, a dialysis membrane has been developed to achieve the efficient removal of beta-2 microglobulin (β2MG), which could not be removed with previous hemodialysis (HD) membranes. Recently, there has been an increase in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7494ac05702de72199ac4bbb986b99c6
https://pubmed.ncbi.nlm.nih.gov/30991407
https://pubmed.ncbi.nlm.nih.gov/30991407
Background With the advancement of technology, a dialysis membrane has been developed to achieve the efficient removal of beta-2 microglobulin (β2MG), which could not be removed with previous hemodialysis (HD) membranes. Recently, there has been an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::989c6fd26129574bc0e2875cbbf8125b
https://doi.org/10.1159/000496527
https://doi.org/10.1159/000496527
Publikováno v:
Nephrology Dialysis Transplantation. 31:1588-1594
Recent reports have shown that novel phosphate binders containing iron are not only efficacious for the treatment of hyperphosphatemia but also may reduce the need for erythropoiesis-stimulating agents and intravenous (IV) iron for anemia management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3c69b02ed609f097a1193a766751b53
https://doi.org/10.1093/ndt/gfv268
https://doi.org/10.1093/ndt/gfv268
Autor:
Masatoshi Nanami, Wataru Fukao, Satoko Masachika, Yukiko Hasuike, Mari Kantou, Takahide Iwasaki, Kazuhiro Toyoda, Yasuyuki Nagasawa, Mana Yahiro, Takeshi Nakanishi, Tomo Yamakawa, Makoto Aichi, Shoko Ikeda Takahishi, Takahiro Kuragano
Publikováno v:
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation. 28(4)
Objective Iron administration affects serum levels of intact (I-) fibroblast growth factor-23 (FGF23) and its cleavage product C-terminal (C-) FGF23 in iron-deficient patients on maintenance hemodialysis (MHD). The objective of this study was to comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7ba9c55a43a47c73ff8a19ca78b4cd9
https://pubmed.ncbi.nlm.nih.gov/29703633
https://pubmed.ncbi.nlm.nih.gov/29703633